基本信息
views: 229
Career Trajectory
Bio
I am a medical oncologist who cares for people with genitourinary cancer. I focus on the management of advanced cancers of the kidney. I am a strong believer in patient education, shared decision-making, and the importance of recognizing that these cancers and therapies can have a tremendous impact on the day-to-day lives of patients and their families. I work as part of an expert team of surgeons, pathologists, radiation oncologists, and medical oncologists at MSK. We collaborate closely to provide the best possible care to our patients.
Read more
My research focuses on the development of new treatments for people with advanced kidney cancer, particularly immunotherapy. Our team seeks to improve the current standards of care through the design and conduct of clinical trials. I have served as the principal investigator for many clinical trials in the United States and internationally.
I also collaborate closely with various scientists at MSK. Our goal is to better understand the intricate genomic and molecular background of renal cell carcinoma. Ultimately, our work in the laboratory aims to lay the foundation for a more individualized approach to our patients’ treatments.
My research efforts have been recognized by the Conquer Cancer Foundation, the American Cancer Society, and the Kidney Cancer Association.
Read more
My research focuses on the development of new treatments for people with advanced kidney cancer, particularly immunotherapy. Our team seeks to improve the current standards of care through the design and conduct of clinical trials. I have served as the principal investigator for many clinical trials in the United States and internationally.
I also collaborate closely with various scientists at MSK. Our goal is to better understand the intricate genomic and molecular background of renal cell carcinoma. Ultimately, our work in the laboratory aims to lay the foundation for a more individualized approach to our patients’ treatments.
My research efforts have been recognized by the Conquer Cancer Foundation, the American Cancer Society, and the Kidney Cancer Association.
Research Interests
Papers共 395 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Martin H. Voss,Howard Gurney, Vagif Atduev,Cristina Suarez, Miguel Angel Climent, David William Pook,Piotr Tomczak, Philippe Barthelemy, Jae-Lyun Lee, Taron Nalbandian,Viktor Stus,Thomas Ferguson,Pawel Wiechno,Erhan Gokmen,Louis Lacombe,Craig Gedye,Joseph E. Burgents,Manish Sharma,Jerry Cornell,Laurence Albiges
JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2024): 2-2
New England journal of medicine/The New England journal of medicineno. 15 (2024): 1432-1433
Anas Badri, Brendan John Guercio,Neha Ratna, David Gavrilov, Nicholina Metzker,Cihan Duzgol, Min Yuen Teo,Ashley M. Regazzi, Lauren Supplice, Samuel A. Funt, David H. Aggen,Martin H. Voss, Marie Isabel Carlo,Neil J. Shah,Robert J. Motzer,Dean F. Bajorin,Jonathan E. Rosenberg,Chung-Han Lee,Ritesh R. Kotecha,Gopa Iyer
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)
Lisa Falchetto, Bernd Bender, Ian Erhard,Kim N. Zeiner,Jan A. Stratmann,Florestan J. Koll,Sebastian Wagner, Marcel Reiser,Khayal Gasimli,Angelika Stehle,Martin Voss,Olivier Ballo,Jörg Janne Vehreschild,Daniel Maier
BMC RESEARCH NOTESno. 1 (2024)
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 7 (2024)
pubmed(2024)
BMJ oncologyno. 1 (2024): e000181-e000181
Stephen Reese,Burcin Agridag Ucpinar,Kelly Fitzgerald,Andrea Knezevic,Lennert Eismann, Mark S. Dawidek,Robert Motzer,Martin Voss,Johnathan Coleman,Paul Russo, Yousef Mazaheri Tehrani,Yingbei Chen,Ritesh R. Kotecha,Oguz Akin,A. Ari Hakimi
Load More
Author Statistics
#Papers: 397
#Citation: 15609
H-Index: 49
G-Index: 122
Sociability: 8
Diversity: 0
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn